查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1831636

人体微生物群治疗药市场，规模，占有率，趋势，产业分析报告:各产品，各治疗领域，各适应症，方法，各地区，2025年～2034年的市场预测

Human Microbiome Therapeutics Market Size, Share, Trends, Industry Analysis Report By Product (Probiotics, Prebiotics, Medical Foods, Prescription Drugs), By Therapeutic Area, By Indication, By Approach, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 最近的一项研究，预计到 2034 年，人类微生物组疗法市场规模将达到 78.9 亿美元。本研究报告详细分析了当前的市场动态和未来的市场成长。

人类微生物组疗法是指旨在靶向、恢復或改变人类微生物组（包括细菌、病毒、真菌和古菌在内的多种微生物群落）组成和活性的疗法。这些疗法旨在利用微生物组的有益特性来预防、治疗和控制各种疾病。这些疗法包括活体生物疗法产品、微生物群落、基因工程微生物、益生元和后生元。人类微生物组疗法的应用涵盖多个治疗领域。在胃肠病学领域，微生物被用于治疗艰难梭菌感染、发炎性肠道疾病 (IBD) 和肠躁症 (IBS)。在肿瘤学领域，调节影响免疫功能的肠道菌丛可以增强免疫疗法的疗效。

以微生物为基础的干预措施也正在被研究用于治疗代谢性疾病，例如肥胖症和 2 型糖尿病；神经系统疾病，例如自闭症谱系障碍和帕金森氏症；以及皮肤疾病，例如湿疹和痤疮。此外，以微生物为基础的干预措施也正在被研究用于预防过敏和治疗女性健康问题，例如细菌性阴道炎。这些疗法可以透过口服胶囊、膳食补充剂、粪便微生物移植 (FMT) 或外用製剂给药。微生物组定序、合成生物学和个人化医疗的进步正在推动该领域的快速发展。

人类微生物组疗法市场报告亮点

按产品划分，益生菌细分市场在2024年占了显着的收入占有率，这主要归功于其在治疗胃肠道疾病、增强免疫力以及恢復肠道菌群平衡方面的广泛应用。

按应用划分，消化和胃肠道疾病在2024年占了最大的收入占有率，这主要归因于肠躁症、发炎性肠道疾病、艰难梭菌感染和抗生素相关腹泻等疾病在全球范围内的高发。

就生产而言，艰难梭菌感染细分市场在2024年占了主导地位，这主要归因于其高復发率、日益严重的抗生素抗药性以及对替代传统抗生素疗法的有效治疗方案的迫切需求。

2024年，北美人类微生物组疗法市场占全球48.15%的收入占有率。这一主导地位主要归因于肥胖、糖尿病和发炎性肠道疾病（IBD）等慢性疾病的日益增加。

预计未来几年，亚太地区的该产业将以最快的速度成长，这主要得益于人们健康意识的提高和可支配收入的增加。

全球人类微生物组疗法市场的主要企业包括：Enterome SA、Ferring Pharmaceuticals、Finch Therapeutics Group Inc.、Locus Biosciences Inc.、MaaT Pharma、Microbiotica Ltd.、Osel Inc.、Seres Therapeutics Inc.、Synlogic Inc. 和 Vedanta Biosciences。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球人体微生物群治疗药市场洞察

  • 市场概述
  • 人体微生物群治疗药市场动态
    • 促进因素和机会
      • 慢性病高发生
      • 日益关注个人化医疗
    • 限制因素和挑战
      • 缺乏可靠的临床数据和认知度
  • PESTEL 分析
  • 人类微生物组疗法市场趋势
  • 价值链分析

第5章 全球人体微生物群治疗药市场:各产品

  • 主要调查结果
  • 简介
  • 益生菌
  • 益生元
  • 医疗用食品
  • 处方药

第6章 全球人体微生物群治疗药市场:各治疗领域

  • 主要调查结果
  • 简介
  • 自体免疫疾病
  • 牙科疾病
  • 消化器官系统及肠胃系统的疾病
  • 皮肤疾病
  • 感染疾病
  • 代谢障碍
  • 肿瘤学
  • 其他

第7章 全球人体微生物群治疗药市场:各适应症

  • 主要调查结果
  • 简介
  • 庹平常性za疮
  • 异位性皮肤炎
  • 难辨梭状芽孢桿菌传染病
  • 大肠癌症
  • 糖尿病
  • 发炎性肠道疾病(IBD)
  • 乳糖不耐症
  • 肺癌症
  • 乳糖不耐症
  • 非酒精性脂肪肝炎(NASH)
  • 肥胖
  • 乳糜泻

第8章 全球人体微生物群治疗药市场:方法

  • 主要调查结果
  • 简介
  • 低分子治疗
  • 单一股的全细菌
  • 微生物联盟
  • 基因改造单一菌株
  • 噬菌体鸡尾酒
  • 微生物生态系统

第9章 全球人体微生物群治疗药市场:各地区

  • 主要调查结果
  • 简介
    • 人体微生物群治疗药市场评估:地区，2020-2034年
  • 北美
    • 北美:各产品，2020～2034年
    • 北美:各治疗领域，2020～2034年
    • 北美:各适应症，2020～2034年
    • 北美:各方法，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品，2020～2034年
    • 欧洲:各治疗领域，2020～2034年
    • 欧洲:各适应症，2020～2034年
    • 欧洲:各方法，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品，2020～2034年
    • 亚太地区:各治疗领域，2020～2034年
    • 亚太地区:各适应症，2020～2034年
    • 亚太地区:各方法，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2020～2034年
    • 中东·非洲:各治疗领域，2020～2034年
    • 中东·非洲:各适应症，2020～2034年
    • 中东·非洲:各方法，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各产品，2020-2034年
    • 南美:各治疗领域，2020-2034年
    • 南美:各适应症，2020-2034年
    • 南美:各方法，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • Enterome Sa
  • Ferring Pharmaceuticals
  • Finch Therapeutics Group Inc.
  • Locus Biosciences Inc.
  • Maat Pharma
  • Microbiotica Ltd
  • Osel Inc.
  • Seres Therapeutics Inc.
  • Synlogic Inc.
  • Vedanta Biosciences
Product Code: PM1687

The human microbiome therapeutics market size is expected to reach USD 7.89 billion by 2034, according to a new study by Polaris Market Research. The report "Human Microbiome Therapeutics Market Share, Size, Trends, Industry Analysis Report By Product (Probiotics, Prebiotics, Medical Foods, Prescription Drugs), By Therapeutic Area, By Indication, By Approach, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human microbiome therapeutics refers to a class of medical treatments designed to target, restore, or modify the composition and activity of the human microbiome, the diverse community of microorganisms, including bacteria, viruses, fungi, and archaea, that live in and on the human body. These therapeutics aim to harness the beneficial properties of the microbiome to prevent, treat, or manage various diseases. They may involve the use of live biotherapeutic products, microbial consortia, genetically engineered microbes, prebiotics, or postbiotics. The usage of human microbiome therapeutics spans multiple therapeutic areas. In gastroenterology, they are used to treat conditions such as Clostridioides difficile infections, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). In oncology, they can enhance responses to immunotherapy by modulating gut bacteria that influence immune function.

They are being explored for metabolic disorders such as obesity and type 2 diabetes, neurological conditions like autism spectrum disorder and Parkinson's disease, and skin disorders including eczema and acne. Additionally, microbiome-based interventions are being investigated for allergy prevention and women's health issues, such as bacterial vaginosis. These therapeutics can be administered through oral capsules, dietary supplements, fecal microbiota transplantation (FMT), or topical formulations. The field is rapidly evolving due to advances in microbiome sequencing, synthetic biology, and personalized medicine.

Human Microbiome Therapeutics Market Report Highlights

In terms of product, the probiotics segment accounted for a major revenue share in 2024 due to their widespread use in managing gastrointestinal disorders, enhancing immune health, and restoring gut microbiota balance.

Based on application, the digestive and gastrointestinal disorders held the largest revenue share in 2024 due to high global prevalence of conditions such as irritable bowel syndrome, inflammatory bowel disease, Clostridioides difficile infection, and antibiotic-associated diarrhea.

In terms of manufacturing, the clostridium difficile infection segment dominated the revenue share in 2024 due to high recurrence rates, growing antibiotic resistance, and the urgent need for effective alternatives to conventional antimicrobial therapies.

North America human microbiome therapeutics market accounted for 48.15% of global revenue share in 2024. This dominance is attributed to the rising incidences of chronic diseases such as obesity, diabetes, and inflammatory bowel disease (IBD).

The industry in Asia Pacific is projected to grow at the fastest pace in the coming years, owing to increasing healthcare awareness and rising disposable incomes.

A few key players in the global human microbiome therapeutics market include Enterome SA, Ferring Pharmaceuticals, Finch Therapeutics Group Inc., Locus Biosciences Inc., MaaT Pharma, Microbiotica Ltd, Osel Inc., Seres Therapeutics Inc., Synlogic Inc., and Vedanta Biosciences.

Polaris Market Research has segmented the global human microbiome therapeutics market report on the basis of product, therapeutic area, indication, approach, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Probiotics

Prebiotics

Medical Foods

Prescription Drugs

By Therapeutic Area Outlook (Revenue, USD Billion, 2020-2034)

Autoimmune Disorders

Dental Disorders

Digestive and Gastrointestinal Disorders

Dermatological Disorders

Infectious Disease

Metabolic Disorders

Oncology

Others

By Indication Outlook (Revenue, USD Billion, 2020-2034)

Acne Vulgaris

Atopic Dermatitis

Clostridium difficile Infection

Colorectal Cancer

Diabetes

Inflammatory Bowel Disease (IBD)

Lactose Intolerance

Lung Cancer

Non-alcoholic steatohepatitis (NASH)

Obesity

Coeliac Disease

By Approach Outlook (Revenue, USD Billion, 2020-2034)

Small Molecule Therapies

Single Strain Whole Bacteria

Microbial Consortia

Genetically Modified Single Strain Bacteria

Phage Cocktail

Microbial Ecosystems

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Human Microbiome Therapeutics Market Insights

  • 4.1. Human Microbiome Therapeutics Market - Market Snapshot
  • 4.2. Human Microbiome Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. High Prevalence of Chronic Diseases
      • 4.2.1.2. Growing Focus on Personalized Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Robust Clinical Data and Awareness
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Human Microbiome Therapeutics Market Trends
  • 4.6. Value Chain Analysis

5. Global Human Microbiome Therapeutics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Probiotics
    • 5.3.1. Global Human Microbiome Therapeutics Market, by Probiotics, by Region, 2020-2034 (USD Billion)
  • 5.4. Prebiotics
    • 5.4.1. Global Human Microbiome Therapeutics Market, by Prebiotics, by Region, 2020-2034 (USD Billion)
  • 5.5. Medical Foods
    • 5.5.1. Global Human Microbiome Therapeutics Market, by Medical Foods, by Region, 2020-2034 (USD Billion)
  • 5.6. Prescription Drugs
    • 5.6.1. Global Human Microbiome Therapeutics Market, by Prescription Drugs, by Region, 2020-2034 (USD Billion)

6. Global Human Microbiome Therapeutics Market, by Therapeutic Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 6.3. Autoimmune Disorders
    • 6.3.1. Global Human Microbiome Therapeutics Market, by Autoimmune Disorders, by Region, 2020-2034 (USD Billion)
  • 6.4. Dental Disorders
    • 6.4.1. Global Human Microbiome Therapeutics Market, by Dental Disorders, by Region, 2020-2034 (USD Billion)
  • 6.5. Digestive and Gastrointestinal Disorders
    • 6.5.1. Global Human Microbiome Therapeutics Market, by Digestive and Gastrointestinal Disorders, by Region, 2020-2034 (USD Billion)
  • 6.6. Dermatological Disorders
    • 6.6.1. Global Human Microbiome Therapeutics Market, by Dermatological Disorders, by Region, 2020-2034 (USD Billion)
  • 6.7. Infectious Disease
    • 6.7.1. Global Human Microbiome Therapeutics Market, by Infectious Disease, by Region, 2020-2034 (USD Billion)
  • 6.8. Metabolic Disorders
    • 6.8.1. Global Human Microbiome Therapeutics Market, by Metabolic Disorders, by Region, 2020-2034 (USD Billion)
  • 6.9. Oncology
    • 6.9.1. Global Human Microbiome Therapeutics Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 6.10. Others
    • 6.10.1. Global Human Microbiome Therapeutics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Human Microbiome Therapeutics Market, by Indication

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • 7.3. Acne Vulgaris
    • 7.3.1. Global Human Microbiome Therapeutics Market, by Acne Vulgaris, by Region, 2020-2034 (USD Billion)
  • 7.4. Atopic Dermatitis
    • 7.4.1. Global Human Microbiome Therapeutics Market, by Atopic Dermatitis, by Region, 2020-2034 (USD Billion)
  • 7.5. Clostridium difficile Infection
    • 7.5.1. Global Human Microbiome Therapeutics Market, by Clostridium difficile Infection, by Region, 2020-2034 (USD Billion)
  • 7.6. Colorectal Cancer
    • 7.6.1. Global Human Microbiome Therapeutics Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
  • 7.7. Diabetes
    • 7.7.1. Global Human Microbiome Therapeutics Market, by Diabetes, by Region, 2020-2034 (USD Billion)
  • 7.8. Inflammatory Bowel Disease (IBD)
    • 7.8.1. Global Human Microbiome Therapeutics Market, by Inflammatory Bowel Disease (IBD), by Region, 2020-2034 (USD Billion)
  • 7.9. Lactose Intolerance
    • 7.9.1. Global Human Microbiome Therapeutics Market, by Lactose Intolerance, by Region, 2020-2034 (USD Billion)
  • 7.10. Lung Cancer
    • 7.10.1. Global Human Microbiome Therapeutics Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
  • 7.11. Lactose Intolerance
    • 7.11.1. Global Human Microbiome Therapeutics Market, by Lactose Intolerance, by Region, 2020-2034 (USD Billion)
  • 7.12. Non-alcoholic steatohepatitis (NASH)
    • 7.12.1. Global Human Microbiome Therapeutics Market, by Non-alcoholic steatohepatitis (NASH), by Region, 2020-2034 (USD Billion)
  • 7.13. Obesity
    • 7.13.1. Global Human Microbiome Therapeutics Market, by Obesity, by Region, 2020-2034 (USD Billion)
  • 7.14. Coeliac Disease
    • 7.14.1. Global Human Microbiome Therapeutics Market, by Coeliac Disease, by Region, 2020-2034 (USD Billion)

8. Global Human Microbiome Therapeutics Market, by Approach

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • 8.3. Small Molecule Therapies
    • 8.3.1. Global Human Microbiome Therapeutics Market, by Small Molecule Therapies, by Region, 2020-2034 (USD Billion)
  • 8.4. Single Strain Whole Bacteria
    • 8.4.1. Global Human Microbiome Therapeutics Market, by Single Strain Whole Bacteria, by Region, 2020-2034 (USD Billion)
  • 8.5. Microbial Consortia
    • 8.5.1. Global Human Microbiome Therapeutics Market, by Microbial Consortia, by Region, 2020-2034 (USD Billion)
  • 8.6. Genetically Modified Single Strain Bacteria
    • 8.6.1. Global Human Microbiome Therapeutics Market, by Genetically Modified Single Strain Bacteria, by Region, 2020-2034 (USD Billion)
  • 8.7. Phage Cocktail
    • 8.7.1. Global Human Microbiome Therapeutics Market, by Phage Cocktail, by Region, 2020-2034 (USD Billion)
  • 8.8. Microbial Ecosystems
    • 8.8.1. Global Human Microbiome Therapeutics Market, by Microbial Ecosystems, by Region, 2020-2034 (USD Billion)

9. Global Human Microbiome Therapeutics Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Human Microbiome Therapeutics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Human Microbiome Therapeutics Market - North America
    • 9.3.1. North America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
    • 9.3.2. North America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.3. North America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
    • 9.3.4. North America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.3.5. Human Microbiome Therapeutics Market - US
      • 9.3.5.1. US: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.3.6. Human Microbiome Therapeutics Market - Canada
      • 9.3.6.1. Canada: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • 9.4. Human Microbiome Therapeutics Market - Europe
    • 9.4.1. Europe: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.5. Human Microbiome Therapeutics Market - UK
      • 9.4.5.1. UK: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.6. Human Microbiome Therapeutics Market - France
      • 9.4.6.1. France: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.7. Human Microbiome Therapeutics Market - Germany
      • 9.4.7.1. Germany: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.8. Human Microbiome Therapeutics Market - Italy
      • 9.4.8.1. Italy: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.9. Human Microbiome Therapeutics Market - Spain
      • 9.4.9.1. Spain: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.10. Human Microbiome Therapeutics Market - Netherlands
      • 9.4.10.1. Netherlands: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.11. Human Microbiome Therapeutics Market - Russia
      • 9.4.11.1. Russia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.4.12. Human Microbiome Therapeutics Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • 9.5. Human Microbiome Therapeutics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.5. Human Microbiome Therapeutics Market - China
      • 9.5.5.1. China: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.6. Human Microbiome Therapeutics Market - India
      • 9.5.6.1. India: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.7. Human Microbiome Therapeutics Market - Malaysia
      • 9.5.7.1. Malaysia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.8. Human Microbiome Therapeutics Market - Japan
      • 9.5.8.1. Japan: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.9. Human Microbiome Therapeutics Market - Indonesia
      • 9.5.9.1. Indonesia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.10. Human Microbiome Therapeutics Market - South Korea
      • 9.5.10.1. South Korea: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.11. Human Microbiome Therapeutics Market - Australia
      • 9.5.11.1. Australia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.5.12. Human Microbiome Therapeutics Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • 9.6. Human Microbiome Therapeutics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.6.5. Human Microbiome Therapeutics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.6.6. Human Microbiome Therapeutics Market - UAE
      • 9.6.6.1. UAE: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.6.7. Human Microbiome Therapeutics Market - Israel
      • 9.6.7.1. Israel: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.6.8. Human Microbiome Therapeutics Market - South Africa
      • 9.6.8.1. South Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.6.9. Human Microbiome Therapeutics Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • 9.7. Human Microbiome Therapeutics Market - Latin America
    • 9.7.1. Latin America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.7.5. Human Microbiome Therapeutics Market - Mexico
      • 9.7.5.1. Mexico: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.7.6. Human Microbiome Therapeutics Market - Brazil
      • 9.7.6.1. Brazil: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.7.7. Human Microbiome Therapeutics Market - Argentina
      • 9.7.7.1. Argentina: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
    • 9.7.8. Human Microbiome Therapeutics Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Enterome Sa
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Ferring Pharmaceuticals
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Finch Therapeutics Group Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Locus Biosciences Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Maat Pharma
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Microbiotica Ltd
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Osel Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Seres Therapeutics Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Synlogic Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Vedanta Biosciences
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development

List of Tables:

  • Table 1 Global Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 3 Global Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 4 Global Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 5 North America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 6 North America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 7 North America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 8 North America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 9 U.S.: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 10 U.S.: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 11 U.S.: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 12 U.S.: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 13 Canada: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Canada: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 15 Canada: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 16 Canada: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 17 Europe: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Europe: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 19 Europe: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 20 Europe: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 21 UK: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 22 UK: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 23 UK: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 24 UK: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 25 France: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 26 France: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 27 France: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 28 France: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 29 Germany: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 30 Germany: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 31 Germany: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 32 Germany: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 33 Italy: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 34 Italy: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 35 Italy: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 36 Italy: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 37 Spain: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Spain: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 39 Spain: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 40 Spain: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 45 Russia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Russia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 47 Russia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 48 Russia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 57 China: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 58 China: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 59 China: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 60 China: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 61 India: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 62 India: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 63 India: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 64 India: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 69 Japan: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 70 Japan: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 71 Japan: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 72 Japan: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 77 South Korea: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 78 South Korea: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 79 South Korea: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 80 South Korea: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 81 Australia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 82 Australia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 83 Australia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 84 Australia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 97 UAE: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 98 UAE: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 99 UAE: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 100 UAE: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 101 Israel: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 102 Israel: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 103 Israel: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 104 Israel: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 105 South Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 106 South Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 107 South Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 108 South Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 113 Latin America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 114 Latin America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 115 Latin America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 116 Latin America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 117 Mexico: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 118 Mexico: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 119 Mexico: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 120 Mexico: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 121 Brazil: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 122 Brazil: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 123 Brazil: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 124 Brazil: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 125 Argentina: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 126 Argentina: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 127 Argentina: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 128 Argentina: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Human Microbiome Therapeutics Market, by Product, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Human Microbiome Therapeutics Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Human Microbiome Therapeutics Market, by Indication, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Human Microbiome Therapeutics Market, by Approach, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Human Microbiome Therapeutics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Human Microbiome Therapeutics Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Therapeutic Area
  • Figure 9. Global Human Microbiome Therapeutics Market, by Therapeutic Area, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Indication
  • Figure 11. Global Human Microbiome Therapeutics Market, by Indication, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Approach
  • Figure 13. Global Human Microbiome Therapeutics Market, by Approach, 2024 & 2034 (USD Billion)